Latest Breaking News On - Ionis pharmaceuticals stock performance - Page 1 : comparemela.com

Ionis Pharmaceuticals (NASDAQ:IONS – Get Free Report) issued its earnings results on Wednesday. The company reported ($0.06) earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of ($0.78) by $0.72, MarketWatch Earnings reports. The company had revenue of $325.00 million during the quarter, compared to analysts’ expectations of $176.01 million. Ionis Pharmaceuticals had […]

United statesElizabethl hougenStifel nicolausEarnings history for ionis pharmaceuticalsRaymond james financial services advisors incNews ratings for ionis pharmaceuticals dailyHedge funds weigh in on ionis pharmaceuticalsAmerican century companies incIonis pharmaceuticals stock performanceIonis pharmaceuticals incMetlife investment managementJpmorgan chase coIonis pharmaceuticalsFinancial services group incUs bancorpMorgan stanley